2022
DOI: 10.1016/j.molmet.2022.101442
|View full text |Cite
|
Sign up to set email alerts
|

A gene–diet interaction controlling relative intake of dietary carbohydrates and fats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 51 publications
(69 reference statements)
0
4
0
Order By: Relevance
“…While dietary macronutrients (i.e. fat and sugar) engage divergent pathways to communicate with the CNS, we show that alterations to hypothalamic circuitry, specifically AgRP neurons, follow similar mechanistic responses and may present attractive treatment options, especially in an obesogenic food environment that promotes over consumption of many macronutrients [5,[54][55][56].…”
Section: Introductionmentioning
confidence: 87%
“…While dietary macronutrients (i.e. fat and sugar) engage divergent pathways to communicate with the CNS, we show that alterations to hypothalamic circuitry, specifically AgRP neurons, follow similar mechanistic responses and may present attractive treatment options, especially in an obesogenic food environment that promotes over consumption of many macronutrients [5,[54][55][56].…”
Section: Introductionmentioning
confidence: 87%
“…Metabolic studies were performed as previously described [ [27] , [28] , [29] ]. In brief, during metabolic monitoring, mice were singly housed for 3 days before measurements were taken and allowed one day to acclimatize in CLAMS chambers (Oxymax®-CLAMS; Columbus Instruments.).…”
Section: Methodsmentioning
confidence: 99%
“…[141][142][143] Furthermore, such an I-TENG-based monitoring system could be expanded to other cardiovascular-related diseases, such as diabetes and obesity, as well as to daily monitoring of patients' diet, alcohol consumption, and other metabolic factors in the prevention and proactive treatment of cardiovascular diseases. [144][145][146][147][148][149][150] For the cardiovascular healthcare systems, as reviewed in the previous sections, implantable self-powered therapeutic devices provide promising aspects within the ever-evolving IoT and the ever-increasing demand for personalized healthcare [151] (Figure 7a). Such point-to-point care system tackles the issue of time and money consuming of traditional cardiovascular healthcare systems.…”
Section: Conclusion and Prospectivementioning
confidence: 99%